Silence Therapeutics plc
corporate_fare Company Profile
Silence Therapeutics plc (NASDAQ:SLN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for SLN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Silence Therapeutics Files $300M Shelf Registration, Including $100M At-The-Market Offering
- Silence Therapeutics Reports Significantly Reduced Q1 Net Loss, Increased Revenue, and Extended Cash Runway into 2028
- Silence Therapeutics Reports Halved Q1 Net Loss, Advances Key Clinical Programs
- Silence Therapeutics Reports Doubled Net Loss, Near-Total Revenue Collapse, and Key Collaboration Terminations
- Silence Therapeutics Reports Steep Revenue Decline, Doubled Net Loss, and AstraZeneca Drops SLN312 Program
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$559K
Net Income
-$88.61M
Diluted EPS
-$0.63
Op. Cash Flow
-$62.27M
Free Cash Flow
-$62.33M
Gross Profit
$344K
Operating Income
-$91.08M
Cash & Equivalents
$11.28M
Debt / Equity
0.00×
Net Margin
-158.52×
Shares Outstanding
141.7M sh
Source: 10-K · filed 2026-03-05 · accession 0001193125-26-092591
show_chartPrice Chart
Loading chart...
feed SLN - Filings & News (Page 2)
SLN
May 18, 2026, 4:07 PM EDT
Price at Filing:
$6.23
Real-time Price:
$19.85
Change:
+$13.62 (+219%)
Market Cap:
$1.232B
SLN
May 07, 2026, 8:22 AM EDT
Price at Filing:
$7.36
Real-time Price:
$19.85
Change:
+$12.49 (+170%)
Market Cap:
$1.232B
SLN
May 07, 2026, 8:15 AM EDT
Price at Filing:
$7.36
Real-time Price:
$19.85
Change:
+$12.49 (+170%)
Market Cap:
$1.232B
SLN
Mar 05, 2026, 7:49 AM EST
Price at Filing:
$5.60
Real-time Price:
$19.85
Change:
+$14.25 (+254%)
Market Cap:
$1.232B
SLN
Mar 05, 2026, 7:40 AM EST
Price at Filing:
$5.60
Real-time Price:
$19.85
Change:
+$14.25 (+254%)
Market Cap:
$1.232B